OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cocaine abuse and midbrain circuits: Functional anatomy of hypocretin/orexin transmission and therapeutic prospect
Steven J. Simmons, Taylor A. Gentile
Brain Research (2019) Vol. 1731, pp. 146164-146164
Open Access | Times Cited: 14

Showing 14 citing articles:

Hypocretins (orexins): The ultimate translational neuropeptides
Laura H. Jacobson, Daniël Hoyer, Luı́s de Lecea
Journal of Internal Medicine (2022) Vol. 291, Iss. 5, pp. 533-556
Closed Access | Times Cited: 73

Repurposing the dual orexin receptor antagonist suvorexant for the treatment of opioid use disorder: why sleep on this any longer?
Morgan H. James, Jennifer E. Fragale, R. Nisha Aurora, et al.
Neuropsychopharmacology (2020) Vol. 45, Iss. 5, pp. 717-719
Open Access | Times Cited: 51

A review of physiological functions of orexin: From instinctive responses to subjective cognition
LiBo Xia, Haiyan Liu, Bi Yan Wang, et al.
Medicine (2023) Vol. 102, Iss. 26, pp. e34206-e34206
Open Access | Times Cited: 15

The abuse potential of lemborexant, a dual orexin receptor antagonist, according to the 8 factors of the Controlled Substances Act
Margaret Moline, Shoji Asakura, Carsten Beuckman, et al.
Psychopharmacology (2023) Vol. 240, Iss. 4, pp. 699-711
Open Access | Times Cited: 11

The orexin (hypocretin) neuropeptide system is a target for novel therapeutics to treat cocaine use disorder with alcohol coabuse
Morgan H. James, Jennifer E. Fragale, Shayna L. O’Connor, et al.
Neuropharmacology (2020) Vol. 183, pp. 108359-108359
Open Access | Times Cited: 29

Age-specific treatment effects of orexin/hypocretin-receptor antagonism on methamphetamine-seeking behavior
Natalie E. Zlebnik, Nathan A. Holtz, Victoria C. Lepak, et al.
Drug and Alcohol Dependence (2021) Vol. 224, pp. 108719-108719
Open Access | Times Cited: 25

Introduction to the Special Issue: “Making orexin-based therapies for addiction a reality: What are the steps from here?”
Morgan H. James, Gary Aston‐Jones
Brain Research (2020) Vol. 1731, pp. 146665-146665
Open Access | Times Cited: 22

Targeting the Orexin System for Prescription Opioid Use Disorder
Alessandra Matzeu, Rémi Martin‐Fardon
Brain Sciences (2020) Vol. 10, Iss. 4, pp. 226-226
Open Access | Times Cited: 22

Identifying roles for peptidergic signaling in mice
Kathryn G. Powers, Xin‐Ming Ma, Betty Eipper, et al.
Proceedings of the National Academy of Sciences (2019) Vol. 116, Iss. 40, pp. 20169-20179
Open Access | Times Cited: 16

Non-Opioid Treatments for Opioid Use Disorder: Rationales and Data to Date
Reda Chalhoub, Peter W. Kalivas
Drugs (2020) Vol. 80, Iss. 15, pp. 1509-1524
Open Access | Times Cited: 13

Identifying Novel Roles for Peptidergic Signaling in Mice
Kathryn G. Powers, Xin‐Ming Ma, Betty Eipper, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2019)
Open Access

Overview of withdrawal syndrome mechanisms in different substance abuse addictions: Neuronal circuits and transmitters
Famitafreshi Hamidreza, Karimian Morteza
Journal of Addiction Medicine and Therapeutic Science (2020), pp. 070-076
Open Access

Page 1

Scroll to top